US
If visiting the DiaSorin Site from a region that doesn't coincide with your location, some products may not be available. This is due to regulatory requirements and restrictions.
26/05/23 - 7:10
DIASORIN CONSOLIDATES STRATEGIC PARTNERSHIP WITH MEMED BY SIGNING AN AGREEMENT TO DISTRIBUTE MEMED BV® TEST FOR THE ITALIAN MARKET ON THE MEMED KEY® POINT-OF-NEED PLATFORM (159.38 KB)
Acquisition / Partnership
28/02/23 - 16:06
Sale of Flow Cytometry and Imaging business from DiaSorin to Cytek® Biosciences completed (130.89 KB)
Acquisition / Partnership
13/02/23 - 22:03
CYTEK BIOSCIENCES TO ACQUIRE FLOW CYTOMETRY AND IMAGING BUSINESS FROM DIASORIN (165.22 KB)
Acquisition / Partnership
09/05/22 - 7:02
DiaSorin and B·R·A·H·M·S, part of Thermo Fisher Scientific, partner to develop and commercialize the new LIAISON® B·R·A·H·M·S MR-proADM™ (173.49 KB)
Acquisition / Partnership
14/07/21 - 15:05
DiaSorin announces completion of the Acquisition of Luminex Corporation (566.52 KB)
Acquisition / Partnership
09/07/21 - 7:34
DiaSorin obtains all approvals necessary to complete the acquisition of Luminex (560.68 KB)
Acquisition / Partnership
21/06/21 - 18:49
The Shareholders’ meeting of Luminex Corporation approved the merger of Luminex with a U.S. wholly-owned subsidiary of DiaSorin (395.62 KB)
Acquisition / Partnership
03/06/21 - 7:47
DiaSorin signs agreements with Unifarma and Alliance Healthcare for the distribution in Italian pharmacies of the LIAISON® IQ (523.42 KB)
Acquisition / Partnership
11/04/21 - 19:47
DiaSorin to acquire Luminex Corporation for USD 37.00 per share or approximately USD 1.8 billion (569.09 KB)
Acquisition / Partnership
06/04/21 - 7:06
DiaSorin announces its strategic collaboration with Lumos Diagnostics (438.14 KB)
Acquisition / Partnership
23/09/20 - 7:16
DiaSorin extends its current joint venture with the Chinese Government to open a new manufacturing and research site in China (495.78 KB)
Acquisition / Partnership
08/09/20 - 7:31
DiaSorin and MeMed partner to develop and commercialize novel host immune response based diagnostics solution (506.16 KB)
Acquisition / Partnership
02/03/20 - 8:04
DiaSorin signs an exclusive licensing agreement for molecular diagnostic POC technology (396.06 KB)
Acquisition / Partnership
05/06/19 - 7:38
DiaSorin and QIAGEN collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease (448.98 KB)
Acquisition / Partnership
Immunodiagnostic
09/10/18 - 11:35
DiaSorin and Meridian enter into a strategic collaboration to sell Helicobacter pylori stool antigen test in the United States and in the United Kingdom (471.21 KB)
Acquisition / Partnership
08/01/18 - 9:00
QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems (483.2 KB)
Acquisition / Partnership
08/01/18 - 9:00
QIAGEN and DiaSorin partner to offer fully automated tuberculosis detection with QuantiFERON-TB Gold Plus available on LIAISON analyzer systems (483.2 KB)
Acquisition / Partnership
29/09/17 - 14:15
DiaSorin completes the acquisition of the ELISA immunodiagnostic business portfolio and associated assets from SIEMENS HEALTHINEERS (332.93 KB)
Acquisition / Partnership
25/07/17 - 21:00
DiaSorin to acquire ELISA immunodiagnostic business portfolio and associated assets from SIEMENS HEALTHINEERS (443.45 KB)
Acquisition / Partnership
23/06/17 - 9:30
DiaSorin and TECAN to collaborate in new platform development (755.46 KB)
Acquisition / Partnership
22/06/17 - 19:45
DiaSorin and QIAGEN sign collaboration to expand Liaison test menu through adoption of select QIAGEN assays (430.67 KB)
Acquisition / Partnership
30/08/16 - 2:00
DiaSorin and Beckman Coulter form strategic partnership to bring the LIAISON XL hepatitis and HIV products to the U.S. market (404.63 KB)
Acquisition / Partnership
13/05/16 - 2:00
Acquisition of Focus Diagnostics' Molecular and Immunoassay Product Business (350.22 KB)
Acquisition / Partnership
30/03/16 - 2:00
DiaSorin to acquire Focus Diagnostics' Molecular and Immunoassay Product Business (133.62 KB)
Acquisition / Partnership
20/07/15 - 2:00
DiaSorin and Beckman Coulter sign a distribution agreement for China (238.01 KB)
Acquisition / Partnership
28/01/14 - 1:00
DiaSorin extends its master agreement with Laboratory Corporation of America Holdings till 2018 (336.26 KB)
Acquisition / Partnership
29/10/13 - 1:00
DiaSorin signes a 5-year agreement with Roche (432.42 KB)
Acquisition / Partnership
02/04/13 - 2:00
DiaSorin signs an agreement with Seegene (243.64 KB)
Acquisition / Partnership
30/07/12 - 2:00
DiaSorin in India: JV with Trivitron Healthcare (56.16 KB)
Acquisition / Partnership
04/05/12 - 2:00
NorDiag acquisition (88.87 KB)
Acquisition / Partnership
12/03/12 - 1:00
Agreement with Sonic Healthcare on Vitamin D (179.85 KB)
Acquisition / Partnership
17/02/12 - 1:00
DiaSorin became a member of the ISBT (178.96 KB)
Acquisition / Partnership
06/10/11 - 2:00
Cardinal Health: agreement extended to 2014 (192.57 KB)
Acquisition / Partnership
11/05/11 - 2:00
DiaSorin and Labcorp extend strategic business relationship (100.01 KB)
Acquisition / Partnership
06/05/11 - 2:00
Agreement with Precision System Science Co., LTD (171.54 KB)
Acquisition / Partnership
17/01/11 - 1:00
The Sonic Healthcare Group chooses DiaSorin (181.71 KB)
Acquisition / Partnership
07/07/10 - 2:00
Agreement with Meridian Inc. (182.7 KB)
Acquisition / Partnership
01/06/10 - 2:00
Acquisition of MUREX product line (102.6 KB)
Acquisition / Partnership
10/03/10 - 1:00
Acquisition of MUREX product line (45.5 KB)
Acquisition / Partnership
22/09/08 - 2:00
Agreement in Japan with Advanced Life Science Institute (99.16 KB)
Acquisition / Partnership
09/07/08 - 2:00
Acquisition of Biotrin (99.08 KB)
Acquisition / Partnership